• Toxicity test of products on cell cultures

• Disinfectant efficacy studies by evaluation of viral growth inhibition

• Antiviral activity (excluding HIV, HBV, HCV, HPV) of phytotherapeutic, natural or synthetic products by evaluating viral growth inhibition

• Evaluation of antiviral activity (excluding HIV, HBV, HCV, HPV and BSL3 containment viruses) of a natural or synthetic phytotherapeutic product in vivo(*) on laboratory mice

• In vivo(*) efficacy test for vaccines or antiviral therapeutics (BSL2), on a mouse model

• Serological neutralisation tests for viral agents (BSL2-3)

• Molecular detection of viruses in experimental samples

(*) studies to be agreed about 3 months in advance to obtain the necessary government clearance